共 313 条
[1]
Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424
[2]
Ferlay J(2015)The prognostic value of lymph node status among breast cancer subtypes Am J Surg 209 717-724
[3]
Soerjomataram I(2001)Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer Eur J Cancer 37 991-286
[4]
Siegel RL(2000)Long-term morbidity following axillary dissection in breast cancer patients—clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors Breast Cancer Res Treat 64 275-118
[5]
Torre LA(2010)Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection J Surg Oncol 102 111-4321
[6]
Jemal A(2005)Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial J Clin Oncol 23 4312-553
[7]
Liao GS(1997)Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes Lancet 349 1864-432
[8]
Chou YC(2005)A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer N Engl J Med 349 546-564
[9]
Hsu HM(2005)American society of clinical oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer J Clin Oncol 23 7703-6
[10]
Dai MS(2011)Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial JAMA 305 569-30